FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104485661> ?p ?o ?g. }

• W2104485661 endingPage "429" @default.
• W2104485661 startingPage "418" @default.
• W2104485661 abstract "mTOR inhibitors are emerging as important anti-neoplastic agents with a wide range of clinical applications. The topoisomerase I inhibitor irinotecan is a potent DNA damaging drug, with a broad spectrum of anticancer activities. mTOR appears to enhance cancer cell survival following DNA damage, thus the inhibition of mTOR after irinotecan could theoretically show synergistic activities in patients. Both mTOR inhibitors and irinotecan have been used as single agents in soft tissue sarcomas with limited efficacy. We completed a phase I trial of the combination of the mTOR inhibitor, temsirolimus, and irinotecan in patients with advanced soft tissue sarcoma. Seventeen patients were recruited. The Phase II recommended dose is 20 mg of temsirolimus and 80 mg/m2 of irinotecan administered on weekly basis for three out of four weeks. Most frequently encountered toxicities include cytopenias, fatigue, and gastrointestinal toxicities. Two patients (one with leiomyosarcoma and one with high grade undifferentiated sarcoma) had stable disease for more than 12 months." @default.
• W2104485661 created "2016-06-24" @default.
• W2104485661 creator A5000809181 @default.
• W2104485661 creator A5001304346 @default.
• W2104485661 creator A5056348305 @default.
• W2104485661 creator A5061746536 @default.
• W2104485661 creator A5064214267 @default.
• W2104485661 creator A5074634103 @default.
• W2104485661 creator A5089486616 @default.
• W2104485661 creator A5089850300 @default.
• W2104485661 date "2013-04-11" @default.
• W2104485661 modified "2023-10-18" @default.
• W2104485661 title "A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma" @default.
• W2104485661 cites W1964505940 @default.
• W2104485661 cites W1972893083 @default.
• W2104485661 cites W1975044418 @default.
• W2104485661 cites W1979177925 @default.
• W2104485661 cites W1985504923 @default.
• W2104485661 cites W1999746552 @default.
• W2104485661 cites W2000095508 @default.
• W2104485661 cites W2005777961 @default.
• W2104485661 cites W2013883015 @default.
• W2104485661 cites W2024104654 @default.
• W2104485661 cites W2028682738 @default.
• W2104485661 cites W2029818855 @default.
• W2104485661 cites W2038347115 @default.
• W2104485661 cites W2040182003 @default.
• W2104485661 cites W2055212993 @default.
• W2104485661 cites W2056445663 @default.
• W2104485661 cites W2057840356 @default.
• W2104485661 cites W2064113213 @default.
• W2104485661 cites W2065540838 @default.
• W2104485661 cites W2074883911 @default.
• W2104485661 cites W2077223675 @default.
• W2104485661 cites W2090517335 @default.
• W2104485661 cites W2103885687 @default.
• W2104485661 cites W2112772060 @default.
• W2104485661 cites W2114859236 @default.
• W2104485661 cites W2118677643 @default.
• W2104485661 cites W2127063807 @default.
• W2104485661 cites W2129456748 @default.
• W2104485661 cites W2129834503 @default.
• W2104485661 cites W2136212424 @default.
• W2104485661 cites W2148933046 @default.
• W2104485661 cites W2153867442 @default.
• W2104485661 cites W2158323046 @default.
• W2104485661 cites W2160042784 @default.
• W2104485661 cites W2167188058 @default.
• W2104485661 cites W2209747046 @default.
• W2104485661 cites W2335846412 @default.
• W2104485661 doi "https://doi.org/10.3390/cancers5020418" @default.
• W2104485661 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3730334" @default.
• W2104485661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24216984" @default.
• W2104485661 hasPublicationYear "2013" @default.
• W2104485661 type Work @default.
• W2104485661 sameAs 2104485661 @default.
• W2104485661 citedByCount "8" @default.
• W2104485661 countsByYear W21044856612014 @default.
• W2104485661 countsByYear W21044856612017 @default.
• W2104485661 countsByYear W21044856612018 @default.
• W2104485661 crossrefType "journal-article" @default.
• W2104485661 hasAuthorship W2104485661A5000809181 @default.
• W2104485661 hasAuthorship W2104485661A5001304346 @default.
• W2104485661 hasAuthorship W2104485661A5056348305 @default.
• W2104485661 hasAuthorship W2104485661A5061746536 @default.
• W2104485661 hasAuthorship W2104485661A5064214267 @default.
• W2104485661 hasAuthorship W2104485661A5074634103 @default.
• W2104485661 hasAuthorship W2104485661A5089486616 @default.
• W2104485661 hasAuthorship W2104485661A5089850300 @default.
• W2104485661 hasBestOaLocation W21044856611 @default.
• W2104485661 hasConcept C121608353 @default.
• W2104485661 hasConcept C126322002 @default.
• W2104485661 hasConcept C142724271 @default.
• W2104485661 hasConcept C143998085 @default.
• W2104485661 hasConcept C147897179 @default.
• W2104485661 hasConcept C183713625 @default.
• W2104485661 hasConcept C190283241 @default.
• W2104485661 hasConcept C2776820818 @default.
• W2104485661 hasConcept C2778256501 @default.
• W2104485661 hasConcept C2778629024 @default.
• W2104485661 hasConcept C2779682216 @default.
• W2104485661 hasConcept C2780259306 @default.
• W2104485661 hasConcept C2780752271 @default.
• W2104485661 hasConcept C502942594 @default.
• W2104485661 hasConcept C526805850 @default.
• W2104485661 hasConcept C54355233 @default.
• W2104485661 hasConcept C552990157 @default.
• W2104485661 hasConcept C55493867 @default.
• W2104485661 hasConcept C71924100 @default.
• W2104485661 hasConcept C86554907 @default.
• W2104485661 hasConcept C86803240 @default.
• W2104485661 hasConcept C98274493 @default.
• W2104485661 hasConceptScore W2104485661C121608353 @default.
• W2104485661 hasConceptScore W2104485661C126322002 @default.
• W2104485661 hasConceptScore W2104485661C142724271 @default.
• W2104485661 hasConceptScore W2104485661C143998085 @default.
• W2104485661 hasConceptScore W2104485661C147897179 @default.
• W2104485661 hasConceptScore W2104485661C183713625 @default.

• next